touchPODCAST

touchMDT for touchONCOLOGY

Listen to a gynaecologic oncologist and nurse practitioner discuss the prognostic risk factors for patients with LACC and how best to support patients throughout their treatment journey for optimal outcomes.

The multidisciplinary team

• Gynaecologic oncologist: Prof. Bradley Monk, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education request from AstraZeneca. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncology.com/cme/optimizing-mdt-care-for-locally-advanced-cervical-cancer/

touchMDT for touchONCOLOGY

Listen to a clinical oncologist and a radiation oncologist discuss current treatment approaches for patients with locally advanced cervical cancer using a patient case to illustrate best practice with the standard of care; ongoing clinical trials are also highlighted.

The multidisciplinary team

• Clinical oncologist: Dr Mary McCormack, UK

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education request from AstraZeneca.  This activity is jointly provided by USF Health and touchIME.

For further information visit our website:

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team, plus an EBC survivor, discuss the challenges around implementing SDM for patients with EBC, and how they may be overcome. 

The multidisciplinary team

• Oncology surgeon: Prof. Dr Michael Gnant, Vienna, Austria

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/mdt-optimizing-shared-decision-making-in-ebc/

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss the evidence and share real-world insights from their own clinical practice on the effects SDM has on patient outcomes in EBC.

The multidisciplinary team

• Nurse specialist: Prof. Dr Khatijah Lim Abdullah, Selangor, Malaysia

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/mdt-optimizing-shared-decision-making-in-ebc/

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team, plus an EBC survivor, share their perspectives and own experiences with SDM in EBC, and explore key elements essential for its successful implementation.

The multidisciplinary team

• Medical oncologist: Prof. Frances Boyle, Sydney, Australia

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Lilly USA, LLC (Lilly). This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/mdt-optimizing-shared-decision-making-in-ebc/

touchMDT for touchONCOLOGY

Listen to a gynaecologic oncologist, a clinical oncologist, and a radiation oncologist discuss the role of the MDT in implementing change to best practice care and the importance of keeping up to date with the latest clinical trial data.

The multidisciplinary team

• Gynaecologic oncologist: Prof. Bradley Monk

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education request from AstraZeneca. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/mdt-optimizing-shared-decision-making-in-ebc/

touchSATELLITE SYMPOSIUM for touchOPHTHALMOLOGY

Listen to three leading experts discuss diagnosis, treatment and care provision for patients with neuromyelitis optica spectrum disorder (NMOSD), with updates on the latest data for immunotherapy treatment options and guidance on how to support the holistic management of patients through multidisciplinary teams.

The experts

• Prof. Sean Pittock (Chair), Mayo Clinic, Rochester, MN, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Alexion Pharmaceuticals.  This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchophthalmologyime.org/nmosd-diagnosis-management/

touchSATELLITE SYMPOSIUM for touchNEUROLOGY

Listen to three leading experts discuss diagnosis, treatment and care provision for patients with neuromyelitis optica spectrum disorder (NMOSD), with updates on the latest data for immunotherapy treatment options and guidance on how to support the holistic management of patients through multidisciplinary teams.

The Experts:

• Prof. Sean Pittock (Chair), Mayo Clinic, Rochester, MN, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Alexion Pharmaceuticals.  This activity is jointly provided by USF Health and touchIME.

touchMDT for touchCARDIO

Listen to key experts from a multidisciplinary team discuss latest guideline recommendations for HFrEF therapies and how new and emerging therapies may be incorporated into clinical practice, now and in the future

The multidisciplinary team

• Cardiology nurse specialist: Dr Carol Wade, Baltimore, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Merck & Co., Inc., Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchcardioime.org/multidisciplinary-team-insights-on-the-promise-of-new-and-emerging-treatment-options-for-patients-with-hfref//

touchMDT for touchCARDIO

Listen to key experts from a multidisciplinary team, plus a patient with HFrEF, discuss established therapies for HFrEF and key efficacy and safety considerations for new and emerging therapies

The multidisciplinary team

• Primary care physician: Prof. Ahmet Fuat, Darlington, UK

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Merck & Co., Inc., Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.